Impaired ability of aged human dendritic cells to maintain mucosal tolerance
Impaired ability of aged human dendritic cells to maintain mucosal tolerance
批准号:
8927521
负责人:
Anshu Agrawal
金额:
$30.72万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2019-04-30
关键词:
AffectAgeAirAll-Trans-RetinolAnti-Inflammatory AgentsAnti-inflammatoryAntigen-Presenting CellsAntigensAsthmaB-LymphocytesBacteriaBloodBody SurfaceBreathingCell AgingCell physiologyCellsChronicChronic DiseaseChronic Obstructive Airway DiseaseCytokine ActivationDataDefectDendritic CellsElderlyEnzyme GeneEnzymesEpithelial CellsEsophagusFoodGene ExpressionGenerationsGenesGenital systemGoalsHealthHumanImmuneImmune responseImmune systemInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseInfluenzaIntegrinsInterferon Type IInterleukin-10InvadedLeukocytesLungLung diseasesLymphoidMaintenanceMetabolismMorbidity - disease rateMucous MembraneMusOrganPathway interactionsPlayPneumoniaPopulationPredispositionProductionRXRReceptor SignalingRegulatory T-LymphocyteReportingRespiratory MucosaRespiratory SystemRespiratory Tract InfectionsRetinoic Acid ReceptorRiskRoleSignal PathwaySkinSurfaceT cell responseT-LymphocyteTSLP geneTherapeutic InterventionTimeToxic Environmental SubstancesTretinoinUp-RegulationVitamin Aagedairway inflammationairway remodelingautocrinebasecell agechemokinecytokinedesigneffective therapygastrointestinal systemhuman subjectmigrationmortalitymucosal sitenovelpathogenpreventprogramsrespiratoryresponse
中文摘要
描述(由申请人提供):随着年龄的增长,患呼吸系统疾病的风险明显增加。老年人更容易患流感和肺炎等肺部感染,以及哮喘和阻塞性肺病等慢性疾病。其潜在机制尚不清楚。气道不断暴露于各种各样的吸入抗原,其中大多数是无害的。树突状细胞(dc)是一种关键的先天免疫细胞,它对于启动和产生有效的免疫应答来抵抗入侵的病原体以及维持对无害吸入抗原的耐受性至关重要。维生素A代谢物视黄酸(RA)在呼吸道dc的耐受性诱导中起主要作用。我们的初步数据表明,老年受试者的dc对维甲酸的反应受损,导致耐受性丧失。此外,衰老dc还会影响气道上皮细胞的功能,诱导CXCL-10、cccl -26、cccl -20等多种趋化因子的分泌,吸引其他细胞进入气道,增强炎症反应。因此,我们假设来自老年人的dc在维持呼吸道表面耐受性的能力上受损,从而导致慢性炎症和气道重塑,并增加老年人对呼吸道疾病的易感性。我们提案的具体目的是-1)研究老年人dc对RA反应受损的机制;2)确定老年dc中RA代谢降低的功能后果;3)探讨老年DC RA反应改变对DC-上皮细胞串扰的影响。世界范围内的老年人口正在增加,需要更好地了解老年人对呼吸系统疾病易感性增加的机制,以设计新的和更有效的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): The risk of respiratory diseases increases significantly with advancing age. Elderly people are more prone to lung infections such as influenza and pneumonia and chronic illnesses such as asthma and obstructive pulmonary disease. The underlying mechanisms are not well understood. Airways are continuously being exposed to a wide variety of inhaled antigens majority of which are harmless. Dendritic cells (DCs) are key innate immune cells which are critical for initiation and generation of an effective immune response against invading pathogens as well as for maintaining tolerance against harmless inhaled antigens. Vitamin A metabolite, Retinoic acid (RA) plays a major role in inducing tolerance in respiratory DCs. Our preliminary data suggests that DCs from aged subjects are impaired in their response to retinoic acid resulting in loss of tolerance. Furthermore, aged DCs also affect the functions of airway epithelial cells to induce the secretion of various chemokines such as CXCL-10, CCL-26, and CCL-20 which can attract other cells into the airways and enhance inflammation. Therefore, we hypothesize that DCs from aged are impaired in their capacity to maintain tolerance at the respiratory surfaces which results in chronic inflammation and remodeling of the airways and increases the susceptibility of the elderly to respiratory illnesses. Our specific aims for the proposal are -1) to investigate the mechanisms responsible for impaired response of DCs from elderly to RA; 2) to determine the functional consequences of reduced RA metabolism in aged DCs; 3) to investigate the effect of altered RA response of aged DC on DC-epithelial cell crosstalk. Aged population is increasing worldwide and a better understanding of the mechanisms underlying the increased susceptibility of the elderly to respiratory diseases is required for design of novel and more effective treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
-
批准号:10696138
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2022
-
负责人:Anshu Agrawal
-
依托单位:
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
-
批准号:10358338
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2021
-
负责人:Anshu Agrawal
-
依托单位:
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
-
批准号:10538647
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2021
-
负责人:Anshu Agrawal
-
依托单位:
Impaired ability of aged human dendritic cells to maintain mucosal tolerance
-
批准号:8694995
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2014
-
负责人:Anshu Agrawal
-
依托单位:
Dendritic cell mediated modulation of tolerance by apoptotic cells in aged humans
-
批准号:7148765
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2006
-
负责人:Anshu Agrawal
-
依托单位:
Dendritic cell mediated modulation of tolerance by apoptotic cells in aging
-
批准号:7268013
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2006
-
负责人:Anshu Agrawal
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: